Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia.
Kedhar
Sanjay R
SR
Belair
Marie-Lyne
ML
Jun
Albert S
AS
Sulkowski
Mark
M
Thorne
Jennifer E
JE
D000998:Antiviral Agents / Q000627:therapeutic use; D003320:Corneal Ulcer / Q000188:drug therapy / Q000821:virology*; D003449:Cryoglobulinemia / Q000188:drug therapy / Q000821:virology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015828:Eye Infections, Viral / Q000188:drug therapy / Q000821:virology*; D005260:Female; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008875:Middle Aged; D011092:Polyethylene Glycols; D011241:Prednisone / Q000627:therapeutic use; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use; D015423:Scleritis / Q000188:drug therapy / Q000821:virology*
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; D003520:Cyclophosphamide; C417083:peginterferon alfa-2b; D011241:Prednisone